Literature DB >> 7706778

A prospective comparison of molecular diagnostic techniques for the early detection of cytomegalovirus in liver transplant recipients.

R Patel1, T F Smith, M Espy, D Portela, R H Wiesner, R A Krom, C V Paya.   

Abstract

Forty-one consecutive liver transplant recipients were studied by polymerase chain reaction (PCR) of serum and peripheral blood mononuclear cells, reverse transcription (RT)-PCR of peripheral blood mononuclear cells, and viral blood culture for symptomatic cytomegalovirus (CMV) infection. The techniques were also used to predict the occurrence of CMV infection. For diagnosis of symptomatic CMV infection, the sensitivity and specificity of the different techniques were as follows: PCR of serum, 100% and 45%; RT-PCR, 25% and 97%; PCR of peripheral blood mononuclear cells, 83% and 35%; and blood culture, 83% and 86%, respectively. PCR of serum was positive in 83% of subjects with symptomatic infection before onset compared with 17% positive by blood culture. While viral blood culture was the best technique for the diagnosis of symptomatic CMV infection, PCR of serum was best at predicting the development of symptomatic CMV infection.

Entities:  

Mesh:

Year:  1995        PMID: 7706778     DOI: 10.1093/infdis/171.4.1010

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

1.  A highly sensitive assay for detection and quantitation of human cytomegalovirus DNA in serum and plasma by PCR and electrochemiluminescence.

Authors:  R Boom; C Sol; J Weel; Y Gerrits; M de Boer; P Wertheim-van Dillen
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

2.  Evaluation of PCR primers for cytomegalovirus detection.

Authors:  A Weinberg; S Li
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

3.  Comparison of quantitative cytomegalovirus (CMV) PCR in plasma and CMV antigenemia assay: clinical utility of the prototype AMPLICOR CMV MONITOR test in transplant recipients.

Authors:  A M Caliendo; K St George; S Y Kao; J Allega; B H Tan; R LaFontaine; L Bui; C R Rinaldo
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

4.  Evaluation of the COBAS AMPLICOR CMV MONITOR test for detection of viral DNA in specimens taken from patients after liver transplantation.

Authors:  I G Sia; J A Wilson; M J Espy; C V Paya; T F Smith
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

5.  Comparison of LightCycler-based PCR, COBAS amplicor CMV monitor, and pp65 antigenemia assays for quantitative measurement of cytomegalovirus viral load in peripheral blood specimens from patients after solid organ transplantation.

Authors:  Xiaoli L Pang; Linda Chui; Jayne Fenton; Barbara LeBlanc; Jutta K Preiksaitis
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

6.  Monitoring of cytomegalovirus infection and disease in bone marrow recipients by reverse transcription-PCR and comparison with PCR and blood and urine cultures.

Authors:  J Gozlan; J P Laporte; S Lesage; M Labopin; A Najman; N C Gorin; J C Petit
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

Review 7.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

8.  Biographical Feature: Thomas F. Smith, Ph.D.

Authors:  Erik Munson
Journal:  J Clin Microbiol       Date:  2016-12-21       Impact factor: 5.948

Review 9.  Management of cytomegalovirus infection after solid-organ or stem-cell transplantation. Current guidelines and future prospects.

Authors:  H Hebart; L Kanz; G Jahn; H Einsele
Journal:  Drugs       Date:  1998-01       Impact factor: 9.546

Review 10.  Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation.

Authors:  Raymund R Razonable; Randall T Hayden
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.